NL990017I2 - Produkt voor geregelde triglyceridevoeding van hyperkatabole zoogdieren. - Google Patents

Produkt voor geregelde triglyceridevoeding van hyperkatabole zoogdieren.

Info

Publication number
NL990017I2
NL990017I2 NL990017C NL990017C NL990017I2 NL 990017 I2 NL990017 I2 NL 990017I2 NL 990017 C NL990017 C NL 990017C NL 990017 C NL990017 C NL 990017C NL 990017 I2 NL990017 I2 NL 990017I2
Authority
NL
Netherlands
Prior art keywords
mammal
fatty acids
chain fatty
hyperkatabolic
mammals
Prior art date
Application number
NL990017C
Other languages
English (en)
Other versions
NL990017I1 (nl
Original Assignee
Pharmacia & Upjohjn Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohjn Aktiebolag filed Critical Pharmacia & Upjohjn Aktiebolag
Publication of NL990017I1 publication Critical patent/NL990017I1/nl
Publication of NL990017I2 publication Critical patent/NL990017I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL990017C 1983-01-26 1999-06-02 Produkt voor geregelde triglyceridevoeding van hyperkatabole zoogdieren. NL990017I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/461,077 US4528197A (en) 1983-01-26 1983-01-26 Controlled triglyceride nutrition for hypercatabolic mammals

Publications (2)

Publication Number Publication Date
NL990017I1 NL990017I1 (nl) 1999-08-02
NL990017I2 true NL990017I2 (nl) 2000-07-03

Family

ID=23831126

Family Applications (1)

Application Number Title Priority Date Filing Date
NL990017C NL990017I2 (nl) 1983-01-26 1999-06-02 Produkt voor geregelde triglyceridevoeding van hyperkatabole zoogdieren.

Country Status (11)

Country Link
US (1) US4528197A (nl)
EP (1) EP0121036B1 (nl)
JP (1) JPH0611708B2 (nl)
AT (1) ATE25492T1 (nl)
AU (1) AU574659B2 (nl)
CA (1) CA1216188A (nl)
CY (1) CY1484A (nl)
DE (2) DE10075025I2 (nl)
HK (1) HK102589A (nl)
NL (1) NL990017I2 (nl)
SG (1) SG24189G (nl)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
US4871768A (en) 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US4847296A (en) * 1984-09-13 1989-07-11 Babayan Vigen K Triglyceride preparations for the prevention of catabolism
US4690820A (en) * 1985-06-07 1987-09-01 The State University Of New York High-caloric, high-fat dietary formula
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
DE3641265A1 (de) * 1986-12-03 1988-06-09 Walter Dr Mach Schweineserum mit erhoehtem gehalt an organspezifischen peptiden, seine herstellung und verwendung
US4810726A (en) * 1987-04-01 1989-03-07 New England Deaconess Hospital Corporation Kernel oils and disease treatment
US4832975A (en) * 1987-09-29 1989-05-23 The Procter & Gamble Company Tailored triglycerides having improved autoignition characteristics
US5288512A (en) * 1987-12-15 1994-02-22 The Procter & Gamble Company Reduced calorie fats made from triglycerides containing medium and long chain fatty acids
US5081105A (en) * 1988-01-15 1992-01-14 New England Deaconess Hospital Corporation Method of treating cancer using structured lipids
US4906664A (en) * 1988-01-15 1990-03-06 New England Deaconess Hospital Corporation Nutritional supplement for treatment of cancer cachexia
US4952606A (en) * 1988-04-05 1990-08-28 New England Deaconess Hospital Corporation Structured lipid containing dairy fat
US4863753A (en) * 1988-06-30 1989-09-05 The Procter & Gamble Company Reduced calorie peanut butter
CA2012381C (en) * 1989-03-28 1997-07-01 Paul Seiden Reduced calorie fat compositions containing polyol polyesters and reduced calorie triglycerides
DE69016200T3 (de) * 1989-04-07 2000-01-13 New England Deaconess Hospital Kurzkettige triglyceride.
IT1232161B (it) * 1989-07-31 1992-01-25 Sigma Tau Ind Farmaceuti Uso dell'acido sebacico e di suoi derivati nell'alimentazione enterale e parentaerale e composizioni farmaceutiche contenenti tali composti
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
JPH06507161A (ja) * 1991-05-08 1994-08-11 ノボ　ノルディスク　アクティーゼルスカブ 脂質吸収不良の治療用経腸医薬製剤の製造のための脂質の使用
US5260336A (en) * 1992-04-30 1993-11-09 New England Deaconess Hospital Corporation Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
ZA936724B (en) 1992-09-14 1995-08-14 Vesta Med Pty Ltd Compositions for the treatment and prophylaxis of metabolic disturbances in infants
US5571553A (en) * 1992-09-18 1996-11-05 University Of Medicine And Dentistry Of New Jersey High energy food products containing partially hydrogenated structured lipids
JP3068970B2 (ja) * 1992-11-30 2000-07-24 中部飼料株式会社 子畜用液状飼料組成物
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
AU673700B2 (en) * 1993-01-27 1996-11-21 Scotia Holdings Plc Triglycerides
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5329502A (en) * 1993-12-10 1994-07-12 Haring Chad T Light bending watch apparatus
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
US5885594A (en) * 1997-03-27 1999-03-23 The Procter & Gamble Company Oral compositions having enhanced mouth-feel
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
DE60023125T2 (de) 1999-03-08 2006-06-22 University Of Manitoba, Winnipeg Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
CN1409629A (zh) * 1999-10-19 2003-04-09 藤泽药品工业株式会社 动物的育肥促进剂及育肥促进方法
EP1268498B1 (en) 2000-02-29 2005-04-13 Medicure International Inc. Cardioprotective phosphonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US20020006959A1 (en) * 2000-05-01 2002-01-17 Henderson Samuel T. Use of medium chain triglycerides for the treatment and prevention of Alzheimer's Disease and other diseases resulting from reduced Neuronal Metabolism
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
DE60128912T9 (de) 2000-07-07 2008-06-26 Medicure International Inc. Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
WO2002083120A2 (en) * 2001-04-18 2002-10-24 Prometic Biosciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
KR20020081632A (ko) * 2001-04-19 2002-10-30 (주)라이브맥스 Ｃｌａ가 함유된 재구성 지질의 제조방법 및 이용방법
US8142799B2 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco High potency clinical anti-craving treatment and method of use
US8142800B1 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco Oral high potency clinical anti-craving treatment and method of use
WO2004077938A2 (en) * 2003-03-06 2004-09-16 Accera Inc. Novel chemical entities and methods for their use in treatment of metabolic disorders
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
EP2468273A3 (en) * 2005-06-20 2012-07-11 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
US20070218183A1 (en) * 2006-03-14 2007-09-20 Bunge Oils, Inc. Oil composition of conjugated linoleic acid
KR101634083B1 (ko) 2006-04-03 2016-06-28 액세라인크 나이와 관련된 기억 손상의 치료를 위한 케톤 생성 조성물의 용도
PT2650381T (pt) 2007-07-31 2016-12-29 Accera Inc Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida
JP5674652B2 (ja) * 2008-07-03 2015-02-25 アクセラ・インコーポレーテッド 神経障害の処置のためのアセトアセテートのモノグリセリドおよび誘導体
US8105809B2 (en) * 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives
CN102319212B (zh) * 2011-09-01 2013-08-21 辽宁中海康生物药业有限公司 一种丁酸氯维地平结构脂肪乳及其制备方法
CN113406247B (zh) * 2021-03-31 2023-04-07 广州海关技术中心 一种基于irms、lc-q-tof-ms和多元素分析相结合的大豆产地溯源识别方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4330557A (en) * 1979-05-21 1982-05-18 Claudio Cavazza Acyl-carnitine and use thereof in parenteral administration of triglycerides
JPS57110176A (en) * 1980-12-27 1982-07-08 Snow Brand Milk Prod Co Ltd Nutrious food composition for tube feeding
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet

Also Published As

Publication number Publication date
AU2378484A (en) 1984-08-02
EP0121036B1 (en) 1987-02-25
AU574659B2 (en) 1988-07-14
ATE25492T1 (de) 1987-03-15
NL990017I1 (nl) 1999-08-02
DE10075025I1 (de) 2000-11-09
CA1216188A (en) 1987-01-06
JPS59141522A (ja) 1984-08-14
DE3462389D1 (en) 1987-04-02
US4528197A (en) 1985-07-09
HK102589A (en) 1990-01-05
CY1484A (en) 1989-12-08
DE10075025I2 (de) 2006-02-02
JPH0611708B2 (ja) 1994-02-16
SG24189G (en) 1989-07-14
EP0121036A1 (en) 1984-10-10

Similar Documents

Publication Publication Date Title
NL990017I2 (nl) Produkt voor geregelde triglyceridevoeding van hyperkatabole zoogdieren.
Palmquist A kinetic concept of lipid transport in ruminants. A review
TR199700537A2 (xx) Diyete uygun dengelenmi� s�t �r�n�.
DK0784437T3 (da) Phospholipidholdig fedtblanding med LCP-fedtsyrer
EP0775449B8 (en) Fowl eggs with high content of highly unsaturated fatty acids, process for producing the same, and use thereof
DE69116345D1 (de) Lösliche diätfasernzusammenstellungen und verfahren zur herstellung derselben
DK160351C (da) Diaettilskud med en specifik foroegende virkning paa menneskers stadium 4 soevn
IT1265092B1 (it) Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
ES551348A0 (es) Un procedimiento para la preparacion de una formula hipoalergenica alimenticia enteral mejorada.
SE9403526D0 (sv) New Peptides
DE3470277D1 (en) Dietetic composition
SE9602280D0 (sv) Immunstimulerande lipidformulering
ATE114462T1 (de) Strukturiertes lipid enthaltend milchfett.
AR017216A1 (es) Metodo para regular la fagocitosis de celulas de mamiferos.
DE3878812T2 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE69132833D1 (de) Verfahren zur behandlung von krebs mittels strukturierten lipiden
ES510082A0 (es) "procedimiento para la bioconversion de paja de cereales en productos ricos en proteinas".
Ushio et al. Effect of dietary fatty acids on Ca2+-ATPase activity of the sarcoplasmic reticulum of rainbow trout skeletal muscle
DK199284D0 (da) Diaetetisk eller terapeutisk praeparat
BG104061A (en) Method for fat absorption reduction by an antilipase antibody
Nakajima et al. Oral administration of lactoferrin enhances the productions of IFN-γ and IL-10 in spleen cells cultured with concanavalin A or lipopolysaccharide
ES2164876T3 (es) Procedimiento para la fabricacion de alimentos dieteticos para lactantes y niños prematuros y alimentos dieteticos.
FR2053703A5 (en) Supplementary food for pregnant women
Rössle et al. Intravascular metabolism of a fish oil-supplemented lipid emulsion in an experimental dog model: Effects on plasma and liver lipids, lipoproteins and incorporation of long-chain n3 fatty acids into plasma lipids
Mello et al. The effect of the thyroidectomy in male rats fed two antagonist lipid diets: II. The fatty acid content of lipids of plasma and mitochondria of liver and brain

Legal Events

Date Code Title Description
TC Notification that names of proprietors of granted supplementary protection certificates were modified